This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sanofi. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: **The Innovations of Laurent Goullieux: A Pioneer in Therapeutic Compounds**
Introduction
Laurent Goullieux, an esteemed inventor based in Paris, France, has made a mark in the field of pharmaceuticals with his innovative contributions. With a keen focus on therapeutic applications, he holds a notable patent that underscores his dedication to advancing medical science.
Latest Patents
Goullieux's most prominent patent is titled "3-aminoalkyl-1,3-dihydro-2H-indol-2-one derivatives, preparation thereof and therapeutic use thereof." This invention pertains to novel 3-aminoalkyl-1,3-dihydro-2H-indol-2-one derivatives and details their preparation and therapeutic applications. The compounds described in this patent exhibit strong affinity and high selectivity for human arginine-vasopressin (AVP) V-receptors, with certain derivatives showcasing significant affinity for AVP V-receptors. This innovative work holds promise for therapeutic advancements in medicine.
Career Highlights
Goullieux's professional journey is marked by his alignment with Sanofi, a leading global healthcare company. His involvement here reflects his commitment to research and development in the pharmaceutical sector. Having a patent in his name demonstrates his role as a key contributor to therapeutic innovations.
Collaborations
Throughout his career, Laurent has collaborated with talented coworkers, including Loïc Foulon and Brigitte Pouzet. Their collaboration has undoubtedly fostered an environment ripe for innovation and propelled their collective work forward, leading to significant breakthroughs in therapeutic chemistry.
Conclusion
In summary, Laurent Goullieux represents a remarkable inventor in the field of pharmaceutical innovation. With a groundbreaking patent that focuses on therapeutic compounds with vital applications, he continues to inspire the industry. His collaborations and work at Sanofi underscore the importance of teamwork in achieving extraordinary advancements in science. The future holds great potential for further innovations from this distinguished inventor.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile